Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 14 | 2020 | 312 | 6.080 |
Why?
|
| Long-Term Potentiation | 12 | 2019 | 21 | 3.770 |
Why?
|
| Hippocampus | 14 | 2019 | 185 | 3.720 |
Why?
|
| Neuronal Plasticity | 10 | 2019 | 81 | 3.540 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2020 | 19 | 2.640 |
Why?
|
| Glucagon-Like Peptide 1 | 5 | 2019 | 11 | 2.480 |
Why?
|
| Protein-Serine-Threonine Kinases | 3 | 2018 | 44 | 1.810 |
Why?
|
| Synapses | 6 | 2012 | 85 | 1.620 |
Why?
|
| Dendritic Spines | 2 | 2019 | 4 | 1.390 |
Why?
|
| Signal Transduction | 8 | 2019 | 666 | 1.350 |
Why?
|
| Memory Disorders | 4 | 2015 | 61 | 1.310 |
Why?
|
| Animals | 32 | 2020 | 7297 | 1.290 |
Why?
|
| Peptide Elongation Factor 1 | 3 | 2016 | 3 | 1.210 |
Why?
|
| eIF-2 Kinase | 3 | 2016 | 8 | 1.160 |
Why?
|
| Mice | 18 | 2020 | 2368 | 1.150 |
Why?
|
| Nootropic Agents | 2 | 2019 | 13 | 1.140 |
Why?
|
| Peptides | 3 | 2017 | 118 | 1.040 |
Why?
|
| Disease Models, Animal | 14 | 2020 | 980 | 1.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2014 | 10 | 1.020 |
Why?
|
| Mice, Transgenic | 9 | 2020 | 249 | 0.970 |
Why?
|
| Brain | 3 | 2020 | 930 | 0.930 |
Why?
|
| Elongation Factor 2 Kinase | 2 | 2019 | 3 | 0.820 |
Why?
|
| Long-Term Synaptic Depression | 3 | 2016 | 6 | 0.820 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2017 | 33 | 0.730 |
Why?
|
| Male | 25 | 2020 | 17807 | 0.730 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 83 | 0.730 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2014 | 6 | 0.720 |
Why?
|
| Mice, Inbred C57BL | 8 | 2017 | 711 | 0.710 |
Why?
|
| Down Syndrome | 1 | 2019 | 7 | 0.700 |
Why?
|
| Phosphorylation | 5 | 2019 | 225 | 0.700 |
Why?
|
| Avoidance Learning | 1 | 2019 | 18 | 0.690 |
Why?
|
| Oxidative Stress | 3 | 2019 | 223 | 0.670 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2017 | 2 | 0.640 |
Why?
|
| Shal Potassium Channels | 1 | 2017 | 7 | 0.630 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 41 | 0.620 |
Why?
|
| Enzyme Inhibitors | 3 | 2018 | 162 | 0.610 |
Why?
|
| Lung | 2 | 2017 | 233 | 0.570 |
Why?
|
| Female | 15 | 2020 | 18164 | 0.560 |
Why?
|
| Sepsis | 1 | 2017 | 146 | 0.560 |
Why?
|
| Macrophages | 1 | 2017 | 188 | 0.560 |
Why?
|
| Antioxidants | 2 | 2012 | 114 | 0.510 |
Why?
|
| Humans | 19 | 2020 | 29093 | 0.490 |
Why?
|
| Emodin | 2 | 2004 | 2 | 0.490 |
Why?
|
| Isoenzymes | 3 | 2020 | 63 | 0.490 |
Why?
|
| Mitochondria | 3 | 2014 | 174 | 0.480 |
Why?
|
| Calcium Signaling | 2 | 2004 | 40 | 0.470 |
Why?
|
| Synaptic Transmission | 2 | 2011 | 113 | 0.470 |
Why?
|
| Colon | 2 | 2004 | 56 | 0.460 |
Why?
|
| Mice, Knockout | 3 | 2019 | 425 | 0.450 |
Why?
|
| Urinary Retention | 1 | 2011 | 6 | 0.420 |
Why?
|
| Wnt Proteins | 1 | 2011 | 18 | 0.420 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2011 | 8 | 0.420 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 3717 | 0.410 |
Why?
|
| Superoxides | 1 | 2011 | 17 | 0.400 |
Why?
|
| Oxidants | 1 | 2011 | 15 | 0.400 |
Why?
|
| Gene Expression Regulation | 6 | 2018 | 481 | 0.370 |
Why?
|
| Presenilin-1 | 3 | 2014 | 4 | 0.360 |
Why?
|
| Maze Learning | 4 | 2017 | 17 | 0.340 |
Why?
|
| Protein Synthesis Inhibitors | 3 | 2018 | 12 | 0.310 |
Why?
|
| Sirolimus | 2 | 2018 | 35 | 0.310 |
Why?
|
| Peptide Elongation Factor 2 | 2 | 2019 | 3 | 0.300 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 441 | 0.290 |
Why?
|
| Aged | 7 | 2020 | 9487 | 0.290 |
Why?
|
| Blotting, Western | 3 | 2017 | 281 | 0.290 |
Why?
|
| Muscle, Smooth | 2 | 2004 | 73 | 0.290 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 77 | 0.290 |
Why?
|
| Anisomycin | 2 | 2018 | 4 | 0.290 |
Why?
|
| Cognition Disorders | 3 | 2015 | 390 | 0.280 |
Why?
|
| Rats | 8 | 2013 | 1604 | 0.260 |
Why?
|
| Cytokines | 5 | 2018 | 243 | 0.260 |
Why?
|
| RNA, Messenger | 4 | 2018 | 514 | 0.250 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2014 | 26 | 0.240 |
Why?
|
| Gastrointestinal Motility | 1 | 2003 | 2 | 0.240 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 74 | 0.240 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2014 | 33 | 0.230 |
Why?
|
| Muscle Contraction | 1 | 2004 | 114 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 1218 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2014 | 158 | 0.230 |
Why?
|
| Ubiquinone | 2 | 2012 | 8 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 69 | 0.210 |
Why?
|
| Inflammation Mediators | 3 | 2018 | 101 | 0.210 |
Why?
|
| Neurons | 3 | 2015 | 394 | 0.210 |
Why?
|
| Organophosphorus Compounds | 2 | 2012 | 35 | 0.210 |
Why?
|
| Glucose Tolerance Test | 2 | 2019 | 125 | 0.200 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 379 | 0.190 |
Why?
|
| Electric Stimulation | 2 | 2018 | 102 | 0.190 |
Why?
|
| Forkhead Transcription Factors | 2 | 2017 | 26 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2018 | 118 | 0.190 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 167 | 0.180 |
Why?
|
| Peptide Fragments | 3 | 2012 | 422 | 0.180 |
Why?
|
| Protein Biosynthesis | 2 | 2012 | 46 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 1379 | 0.170 |
Why?
|
| tau Proteins | 1 | 2019 | 38 | 0.170 |
Why?
|
| Biophysics | 1 | 2018 | 9 | 0.170 |
Why?
|
| Hemospermia | 1 | 2018 | 1 | 0.170 |
Why?
|
| Endoscopes | 1 | 2018 | 2 | 0.170 |
Why?
|
| Seminal Vesicles | 1 | 2018 | 4 | 0.170 |
Why?
|
| Calculi | 1 | 2018 | 3 | 0.170 |
Why?
|
| Adenine | 1 | 2018 | 15 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2020 | 469 | 0.160 |
Why?
|
| Indoles | 1 | 2018 | 58 | 0.160 |
Why?
|
| Thalamus | 1 | 2018 | 39 | 0.160 |
Why?
|
| Cecum | 1 | 2017 | 9 | 0.160 |
Why?
|
| Central Nervous System Agents | 1 | 2017 | 3 | 0.160 |
Why?
|
| Superoxide Dismutase | 3 | 2013 | 47 | 0.160 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 40 | 0.150 |
Why?
|
| Behavior, Animal | 1 | 2019 | 264 | 0.150 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 107 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2017 | 64 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2014 | 799 | 0.150 |
Why?
|
| Dacryocystitis | 1 | 2017 | 1 | 0.150 |
Why?
|
| Cathepsins | 1 | 2017 | 3 | 0.150 |
Why?
|
| Tears | 1 | 2017 | 3 | 0.150 |
Why?
|
| Lacrimal Apparatus | 1 | 2017 | 6 | 0.150 |
Why?
|
| Rats, Wistar | 3 | 2013 | 84 | 0.150 |
Why?
|
| Sjogren's Syndrome | 1 | 2017 | 35 | 0.150 |
Why?
|
| Organ Culture Techniques | 1 | 2016 | 38 | 0.140 |
Why?
|
| Apoptosis | 1 | 2017 | 337 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 519 | 0.140 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2015 | 3 | 0.140 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 24 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2015 | 37 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 42 | 0.130 |
Why?
|
| Gene Expression | 1 | 2016 | 332 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2014 | 64 | 0.120 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2014 | 23 | 0.120 |
Why?
|
| Incretins | 1 | 2013 | 2 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2014 | 60 | 0.120 |
Why?
|
| Rodentia | 1 | 2013 | 10 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2014 | 53 | 0.120 |
Why?
|
| Haplorhini | 1 | 2013 | 64 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 2014 | 46 | 0.120 |
Why?
|
| Rest | 1 | 2014 | 49 | 0.120 |
Why?
|
| Coumarins | 1 | 2013 | 2 | 0.120 |
Why?
|
| Graft vs Host Disease | 1 | 2013 | 18 | 0.120 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 17 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2013 | 19 | 0.120 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 49 | 0.110 |
Why?
|
| Hydrogen | 1 | 2013 | 9 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2013 | 18 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2013 | 34 | 0.110 |
Why?
|
| Eukaryotic Initiation Factor-4F | 1 | 2012 | 2 | 0.110 |
Why?
|
| Fluid Therapy | 1 | 2013 | 27 | 0.110 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2012 | 16 | 0.110 |
Why?
|
| Association Learning | 1 | 2012 | 16 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2013 | 28 | 0.110 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 30 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2018 | 670 | 0.110 |
Why?
|
| Resuscitation | 1 | 2013 | 56 | 0.110 |
Why?
|
| Liver Transplantation | 1 | 2013 | 111 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 58 | 0.110 |
Why?
|
| Fear | 1 | 2012 | 44 | 0.110 |
Why?
|
| Cognition | 1 | 2016 | 526 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 747 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2011 | 91 | 0.100 |
Why?
|
| Onium Compounds | 1 | 2011 | 2 | 0.100 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 19 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 28 | 0.100 |
Why?
|
| Mutation | 1 | 2013 | 466 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 97 | 0.100 |
Why?
|
| Middle Aged | 3 | 2020 | 10829 | 0.090 |
Why?
|
| Interneurons | 1 | 2009 | 23 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 72 | 0.090 |
Why?
|
| Dendrites | 1 | 2005 | 15 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2004 | 6 | 0.060 |
Why?
|
| Azepines | 1 | 2004 | 2 | 0.060 |
Why?
|
| Naphthalenes | 1 | 2004 | 39 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2004 | 37 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 10 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2014 | 454 | 0.060 |
Why?
|
| Calcium | 1 | 2004 | 296 | 0.050 |
Why?
|
| Genital Neoplasms, Male | 1 | 2018 | 1 | 0.040 |
Why?
|
| Holmium | 1 | 2018 | 1 | 0.040 |
Why?
|
| Ejaculatory Ducts | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lithotripsy | 1 | 2018 | 12 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 2018 | 18 | 0.040 |
Why?
|
| Lasers, Solid-State | 1 | 2018 | 7 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2018 | 22 | 0.040 |
Why?
|
| Endoscopy | 1 | 2018 | 40 | 0.040 |
Why?
|
| Ophthalmic Solutions | 1 | 2017 | 2 | 0.040 |
Why?
|
| Urethra | 1 | 2018 | 100 | 0.040 |
Why?
|
| Conjunctiva | 1 | 2017 | 5 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 25 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2018 | 389 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 726 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2015 | 2 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2018 | 466 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 2015 | 16 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 337 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 52 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 77 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 95 | 0.030 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2014 | 1 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2014 | 6 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 145 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Cell Count | 1 | 2014 | 50 | 0.030 |
Why?
|
| Dependovirus | 1 | 2014 | 17 | 0.030 |
Why?
|
| Acylation | 1 | 2013 | 1 | 0.030 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2013 | 2 | 0.030 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2013 | 2 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2013 | 2 | 0.030 |
Why?
|
| Venoms | 1 | 2013 | 2 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2014 | 39 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 69 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2014 | 59 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 106 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 2013 | 32 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 18 | 0.030 |
Why?
|
| HMGB1 Protein | 1 | 2013 | 5 | 0.030 |
Why?
|
| Catalase | 1 | 2013 | 16 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 142 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2013 | 34 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2013 | 116 | 0.030 |
Why?
|
| Amine Oxidase (Copper-Containing) | 1 | 2013 | 1 | 0.030 |
Why?
|
| Gases | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hydroxyl Radical | 1 | 2013 | 3 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2013 | 9 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2013 | 82 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 126 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 572 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2013 | 159 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2013 | 75 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 172 | 0.030 |
Why?
|
| Spleen | 1 | 2013 | 82 | 0.030 |
Why?
|
| Sterols | 1 | 2012 | 3 | 0.030 |
Why?
|
| Hydrazones | 1 | 2012 | 3 | 0.030 |
Why?
|
| Nitro Compounds | 1 | 2012 | 4 | 0.030 |
Why?
|
| Peroxidase | 1 | 2013 | 33 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 92 | 0.030 |
Why?
|
| Thiazoles | 1 | 2012 | 32 | 0.030 |
Why?
|
| Acute Disease | 1 | 2013 | 239 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2013 | 148 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2013 | 149 | 0.030 |
Why?
|
| Myocardium | 1 | 2013 | 170 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 242 | 0.030 |
Why?
|
| Insulin | 1 | 2013 | 346 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2108 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 525 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2013 | 573 | 0.020 |
Why?
|
| Weight Loss | 1 | 2013 | 413 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 3 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2009 | 9 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 25 | 0.020 |
Why?
|
| Neprilysin | 1 | 2009 | 32 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 72 | 0.020 |
Why?
|
| Aging | 1 | 2015 | 881 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2009 | 256 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 2001 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 2402 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3099 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 3254 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2005 | 28 | 0.020 |
Why?
|
| Base Sequence | 1 | 2005 | 240 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 350 | 0.020 |
Why?
|
| Adult | 1 | 2013 | 8420 | 0.010 |
Why?
|